Literature DB >> 27910812

Inflammatory markers associated with abdominal aortic aneurysm.

Sarah Lindberg1, Moncef Zarrouk1, Jan Holst1, Anders Gottsäter1.   

Abstract

PURPOSE: Inflammation with leukocytic infiltration, degradation of extracellular matrix (ECM), and depletion of vascular smooth muscle cells (VSMC) are pathological hallmarks of abdominal aortic aneurysm (AAA). The aim of this study was to further evaluate relationships between AAA and inflammatory biomarkers, interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α), endothelin-1 (ET-1) and soluble urokinase-type plasminogen activator receptor (suPAR), by comparing levels in 65-year-old men with and without AAA at ultrasound screening. We also evaluated whether any biomarker can independently predict AAA at screening, and clarified potential correlations between aortic diameter and blood levels of these biomarkers.
RESULTS: There were significant (p ≤ 0.05) differences between subjects with and without AAA for the following variables: p-leukocyte count (TLC) (p<0.001), p-homocysteine (p<0.001), p-TNF-α (p = 0.023), p-IL-6 (p<0.001), p-ET-1 (p = 0.002), p-suPAR (p<0.001), ankle brachial index (ABI) (p<0.001), plasma (p)-creatinine (p = 0.049), p-total cholesterol (p<0.001), p-high density lipoprotein (HDL) (p<0.001) and low density lipoprotein (LDL) cholesterol (p = 0.001), smoking habits (p<0.001), and use of antihypertensive (p<0.001) and lipid-lowering (p = 0.001) drugs. When the above variables were stepwise excluded in a logistic regression model, only p-IL-6 (p = 0.002), p-homocysteine (p = 0.015), p-HDL (p = 0.004), ABI in the right (p = 0.005) and left (p = 0.094) leg, smoking habits (p = 0.003), and antihypertensive drug use (p = 0.045), differed between groups. Significant correlations with aortic diameter existed for p-TNF-α (p = 0.028), p-IL-6 (p<0.001), p-ET-1 (p = 0.002) and p-suPAR (p<0.001) in the entire study population, and for p-TNF-α (p = 0.023), p-ET-1 (p = 0.009) and p-suPAR (p = 0.001) among men with AAA.
CONCLUSIONS: Several inflammatory biomarkers were significantly elevated and correlated with aortic diameter among 65-year old men with AAA at ultrasound screening. IL-6, homocysteine and use of antihypertensive medication remained elevated in the logistic regression model, together with known risk markers for AAA such as smoking and signs of atherosclerosis.

Entities:  

Keywords:  ET-1; IL-6; SuPAR; TNF-alpha; abdominal aortic aneurysm; biomarkers

Mesh:

Substances:

Year:  2016        PMID: 27910812     DOI: 10.1684/ecn.2016.0381

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  13 in total

1.  The pathogenesis shared between abdominal aortic aneurysms and intracranial aneurysms: a microarray analysis.

Authors:  Wen Wang; Hao Li; Zheng Zhao; Haoyuan Wang; Dong Zhang; Yan Zhang; Qing Lan; Jiangfei Wang; Yong Cao; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2017-10-14       Impact factor: 3.042

2.  Blood biomarker panel recommended for personalized prediction, prognosis, and prevention of complications associated with abdominal aortic aneurysm.

Authors:  Jiri Molacek; Vladislav Treska; Jan Zeithaml; Ivana Hollan; Ondrej Topolcan; Ladislav Pecen; David Slouka; Marie Karlikova; Radek Kucera
Journal:  EPMA J       Date:  2019-06-03       Impact factor: 6.543

3.  Meprin-α (Mep1A) enhances TNF-α secretion by mast cells and aggravates abdominal aortic aneurysms.

Authors:  Ran Gao; Duan Liu; Wenjun Guo; Weipeng Ge; Tianfei Fan; Bolun Li; Pan Gao; Bin Liu; Yuehong Zheng; Jing Wang
Journal:  Br J Pharmacol       Date:  2020-03-17       Impact factor: 8.739

4.  Insight into the expression of toll-like receptors 2 and 4 in patients with abdominal aortic aneurysm.

Authors:  Agnieszka Jabłońska; Christoph Neumayer; Michael Bolliger; Christopher Burghuber; Markus Klinger; Svitlana Demyanets; Josif Nanobachvili; Ihor Huk
Journal:  Mol Biol Rep       Date:  2020-03-07       Impact factor: 2.316

5.  Microarray Analysis Reveals a Potential Role of lncRNA Expression in 3,4-Benzopyrene/Angiotensin II-Activated Macrophage in Abdominal Aortic Aneurysm.

Authors:  Yingying Zhou; Jiaoni Wang; Yangjing Xue; Aili Fang; Shaoze Wu; Kaiyu Huang; Luyuan Tao; Jie Wang; Yigen Shen; Jinsheng Wang; Lulu Pan; Lei Li; Kangting Ji
Journal:  Stem Cells Int       Date:  2017-10-18       Impact factor: 5.443

6.  Chemerin-9 Attenuates Experimental Abdominal Aortic Aneurysm Formation in ApoE-/- Mice.

Authors:  Shuxiao Chen; Chenglin Han; Shuai Bian; Jianfeng Chen; Xuedong Feng; Gang Li; Xuejun Wu
Journal:  J Oncol       Date:  2021-04-17       Impact factor: 4.375

7.  Smoking, Hypertension, and GG Genotype of the IL-6 rs1800796 Polymorphism are Independent Risk Factors for Abdominal Aortic Aneurysm in Han Population.

Authors:  Yuchao Zhang; Gang Xu; Ping Wang
Journal:  Pharmgenomics Pers Med       Date:  2021-09-07

8.  Detection of Pathological Changes in the Aorta during Thoracic Aortic Aneurysm Progression on Molecular Level.

Authors:  Miroslava Rabajdová; Peter Urban; Ivana Špaková; Artemiou Panagiotis; Michaela Ferenčáková; Dušan Rybár; Nikita Bobrov; František Sabol; Mária Mareková
Journal:  Dis Markers       Date:  2017-10-12       Impact factor: 3.434

9.  Characterization of CD4+ T Cell Subsets in Patients with Abdominal Aortic Aneurysms.

Authors:  Fábio Haach Téo; Rômulo Tadeu Dias de Oliveira; Liana Villarejos; Ronei Luciano Mamoni; Albina Altemani; Fabio Husemann Menezes; Maria Heloisa Souza Lima Blotta
Journal:  Mediators Inflamm       Date:  2018-12-27       Impact factor: 4.711

10.  Daphnetin suppresses experimental abdominal aortic aneurysms in mice via inhibition of aortic mural inflammation.

Authors:  Shiyun Xie; Li Ma; Hongliang Guan; Su Guan; Lijuan Wen; Chanchan Han
Journal:  Exp Ther Med       Date:  2020-10-15       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.